Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Deborah Collyar: What's In It for Patients?

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Oct
17
Today In Oncology
Verifying the Seen and Unseen by AI in Cancer Imaging
AI-Extracted Chart Data for Expanding Surgical Oncology Learnings
Even Highly Curable Childhood Leukemias Take a Substantial Toll on Families
Two Studies Show Breast Cancer Survival and Mortality Gaps Are Widening Between Rural and Urban Areas
Lung Cancer Specialist Apar Kishor Ganti, MD, Shares His Insights
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo